Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
Solid Biosciences Inc. (SLDB)
Hanrahan Jessie — Chief Regulatory Officer
Shares
12,348
Price
$6.44
Total Value
$79.54K
Shares Held After
70,327
% of Holdings
14.9%
Solid Biosciences Inc. (SLDB)
Herzich Paul — Chief Technology Officer
Shares
10,905
Price
$6.44
Total Value
$70.25K
Shares Held After
69,067
% of Holdings
13.6%
Taysha Gene Therapies, Inc. (TSHA)
Alam Kamran — CHIEF FINANCIAL OFFICER
Shares
1,655
Price
$4.52
Total Value
$7.48K
Shares Held After
1,442,131
% of Holdings
0.1%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
996
Price
$350.00
Total Value
$348.60K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
664
Price
$348.79
Total Value
$231.60K
Shares Held After
996
% of Holdings
40.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
10,100
Price
$77.54
Total Value
$783.15K
Shares Held After
708,719
% of Holdings
1.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,900
Price
$76.94
Total Value
$761.67K
Shares Held After
718,819
% of Holdings
1.4%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
509
Price
$32.74
Total Value
$16.66K
Shares Held After
105,211
% of Holdings
0.5%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
2,485
Price
$32.07
Total Value
$79.69K
Shares Held After
105,720
% of Holdings
2.3%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
232
Price
$32.85
Total Value
$7.62K
Shares Held After
105,706
% of Holdings
0.2%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
1,547
Price
$32.11
Total Value
$49.67K
Shares Held After
105,938
% of Holdings
1.4%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
110
Price
$32.90
Total Value
$3.62K
Shares Held After
111,226
% of Holdings
0.1%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
1,635
Price
$32.14
Total Value
$52.55K
Shares Held After
111,336
% of Holdings
1.4%
Verastem, Inc. (VSTM)
Paterson Dan — Director
Shares
970
Price
$6.69
Total Value
$6.49K
Shares Held After
612,919
% of Holdings
0.2%
Spero Therapeutics, Inc. (SPRO)
Keutzer Timothy — Chief Operating Officer
Shares
3,471
Price
$2.24
Total Value
$7.78K
Shares Held After
761,158
% of Holdings
0.5%
OCULAR THERAPEUTIX, INC (OCUL)
Notman Donald — Chief Operating Officer
Shares
6,035
Price
$8.54
Total Value
$51.54K
Shares Held After
377,802
% of Holdings
1.6%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
200
Price
$68.94
Total Value
$13.79K
Shares Held After
211,148
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
100
Price
$67.88
Total Value
$6.79K
Shares Held After
211,348
% of Holdings
0.0%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
1,299
Price
$66.85
Total Value
$86.84K
Shares Held After
211,448
% of Holdings
0.6%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
1,420
Price
$65.83
Total Value
$93.48K
Shares Held After
212,747
% of Holdings
0.7%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
2,481
Price
$64.88
Total Value
$160.97K
Shares Held After
214,167
% of Holdings
1.1%
aTyr Pharma, Inc. (ATYR)
Broadfoot Jill Marie — Chief Financial Officer
Shares
1,558
Price
$0.98
Total Value
$1.52K
Shares Held After
37,296
% of Holdings
4.0%
aTyr Pharma, Inc. (ATYR)
DENYES NANCY — General Counsel
Shares
1,118
Price
$0.98
Total Value
$1.09K
Shares Held After
33,124
% of Holdings
3.3%
aTyr Pharma, Inc. (ATYR)
Shukla Sanjay — Director
Shares
3,745
Price
$0.98
Total Value
$3.66K
Shares Held After
153,553
% of Holdings
2.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's Title: Executive Vice President and Chief Medical Officer
Shares
9,794
Price
$25.81
Total Value
$252.75K
Shares Held After
80,651
% of Holdings
10.8%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
2,602
Price
$45.02
Total Value
$117.14K
Shares Held After
12,546
% of Holdings
17.2%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,000
Price
$1.13
Total Value
$5.65K
Shares Held After
273,866
% of Holdings
1.8%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
1,087
Price
$43.29
Total Value
$47.06K
Shares Held After
22,885
% of Holdings
4.5%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
19,076
Price
$43.29
Total Value
$825.85K
Shares Held After
164,580
% of Holdings
10.4%
UroGen Pharma Ltd. (URGN)
Smith Jason Drew — General Counsel
Shares
3,217
Price
$19.69
Total Value
$63.34K
Shares Held After
55,588
% of Holdings
5.5%
UroGen Pharma Ltd. (URGN)
Smith Jason Drew — General Counsel
Shares
1,608
Price
$19.69
Total Value
$31.66K
Shares Held After
51,326
% of Holdings
3.0%
UroGen Pharma Ltd. (URGN)
Smith Jason Drew — General Counsel
Shares
2,654
Price
$19.69
Total Value
$52.26K
Shares Held After
52,934
% of Holdings
4.8%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
220,000
Price
$4.20
Total Value
$924.00K
Shares Held After
6,429,863
% of Holdings
3.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
7,790
Price
$76.73
Total Value
$597.76K
Shares Held After
708,719
% of Holdings
1.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,659
Price
$75.94
Total Value
$733.54K
Shares Held After
716,509
% of Holdings
1.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,551
Price
$74.88
Total Value
$191.02K
Shares Held After
726,168
% of Holdings
0.4%
ProMIS Neurosciences Inc. (PMN)
ABG Management Ltd. — 10% Owner
Shares
700,741
Price
$12.13
Total Value
$8.50M
Shares Held After
943,090
% of Holdings
74.3%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
20,000
Price
$40.87
Total Value
$817.33K
Shares Held After
1,235
% of Holdings
94.2%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
1,170
Price
$15.25
Total Value
$17.84K
Shares Held After
156,052
% of Holdings
0.7%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
3,000
Price
$14.82
Total Value
$44.47K
Shares Held After
157,222
% of Holdings
1.9%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
323
Price
$1.82
Total Value
$588.51
Shares Held After
514,551
% of Holdings
0.1%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,559
Price
$4.10
Total Value
$22.79K
Shares Held After
550,000
% of Holdings
1.0%
Spero Therapeutics, Inc. (SPRO)
Keutzer Timothy — Chief Operating Officer
Shares
24,224
Price
$2.14
Total Value
$51.84K
Shares Held After
764,629
% of Holdings
3.1%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
1
Price
$18.00
Total Value
$18.00
Shares Held After
358,233
% of Holdings
0.0%
Zentalis Pharmaceuticals, Inc. (ZNTL)
Vultaggio Vincent — PAO and PFO
Shares
556
Price
$2.52
Total Value
$1.40K
Shares Held After
186,730
% of Holdings
0.3%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
29,063
Price
$44.58
Total Value
$1.30M
Shares Held After
3,530,702
% of Holdings
0.8%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
8,120
Price
$19.00
Total Value
$154.28K
Shares Held After
1,179,524
% of Holdings
0.7%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
3,686
Price
$19.69
Total Value
$72.58K
Shares Held After
144,985
% of Holdings
2.5%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
1,843
Price
$19.69
Total Value
$36.29K
Shares Held After
148,671
% of Holdings
1.2%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
1,844
Price
$19.69
Total Value
$36.31K
Shares Held After
150,514
% of Holdings
1.2%
Showing 751–800 of 936 transactions (page 16 of 19)